SCHEMBL26033459

SCHEMBL26033459

O=c1[nH]cc(Br)nc1N1CCCOCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MAPK1 P28482 1/20 0.38
TSHR P16473 2/20 0.38
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
TYMP P19971 1/20 0.35
KDM4E B2RXH2 2/20 0.33
GBA1 P04062 1/20 0.33
PDGFRB P09619 1/20 0.33
LRRK2 Q5S007 2/20 0.33
POLB P06746 1/20 0.33
APAF1 O14727 1/20 0.32
CDC25B P30305 1/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
ELANE P08246 1/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32
RAF1 P04049 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16035978 0.91 LMNA (0.45) ALDH1A1MAPK1TSHRMAPTLMNA
SCHEMBL21552873 0.89 TYMP (0.35) ALDH1A1MAPK1TSHRMAPTTYMP
SCHEMBL21553090 0.87 MAPT (0.41) ALDH1A1MAPK1TSHRMAPTLMNA
SCHEMBL21552889 0.78 HRH4 (0.48) POLB
SCHEMBL21552854 0.77 HRH4 (0.32) KDM4E
SCHEMBL21564771 0.76
SCHEMBL21552826 0.75 KMT2A (0.37) ALDH1A1TSHRLMNAGBA1
SCHEMBL21564560 0.75 HRH4 (0.33)
SCHEMBL21552876 0.75 LRRK2 (0.34) LRRK2
SCHEMBL21552911 0.74 ABL1 (0.49) ALDH1A1MAPK1TSHRMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250090-A1 KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE IMAGO BIOSCIENCES INC (US) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250090-A1 KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE KDM1B, KDM1A, KDM2A ALDH1A1 839/4885MAPK1 2828/4885TSHR 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.